Barclays PLC Nano Vibronix, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$2.77 - $4.5 $80 - $130
-29 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$3.21 - $4.34 $93 - $125
29 New
29 $0
Q2 2018

Aug 14, 2018
SELL
$4.2 - $5.0 $8 - $10
-2 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$4.3 - $4.88 $8 - $9
2 New
2 $0

Others Institutions Holding NAOV

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About NanoVibronix, Inc.

NAOV Quotes by TradingView
  • Ticker NAOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,997,800
  • Market Cap $16.8M
  • Description
  • NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...
More about NAOV
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email